Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
NIHR Journals Library
2009-09-01
|
Series: | Health Technology Assessment |
Online Access: | https://doi.org/10.3310/hta13suppl2/06 |